In March 2020, the health and care system embarked on the most challenging year in its history.
Within a matter of days, all 15 Academic Health Science Networks (AHSNs) realigned resources and refocused our existing work to support the national and regional response to coronavirus (COVID-19). We adapted and channelled our efforts to support the system where the need was the greatest, and used our model of operating as a locally connected, co-ordinated national network to add value at pace and scale during this time.
Our 2020/21 Impact Report demonstrates that as a Network we drive forward results in the most relevant areas to make a real difference for patients and service users, as well as healthcare professionals, innovators and NHS organisations. We use our unique position working across all sectors relevant to health and care and our embedded relationships as a catalyst for the greatest impacts, and this year is a demonstration of how effective that can be.
Even in the face of adversity, the system has made some incredible steps forward to adopt innovation and work even more closely with industry.
Professor Gary Ford
Chair of the AHSN Network and Chief Executive of Oxford AHSN
Dr Stuart Monk, National Programme Director for the Accelerated Access Collaborative (AAC) Programmes at the Health Innovation Network, talks about the pivotal role of innovation tackling healthcare inequalities in the NHS. At the Royal Society of Medicine’s Tackling Inequalities conference it was clear from the passion in the room that great progress has been made [...]
Dr Phil Jennings, Vice Chair of the Health Innovation Network and Chief Executive of Health Innovation North West Coast, discusses why the Network’s collective relicensing gives innovation a better chance of success. In any one day in England, 1.2 million people attend a GP appointment, over a quarter of a million people have an outpatient [...]
Kidney care costs the NHS £1.5bn a year. Minuteful Kidney, from Healthy.io, is a home kidney albumin to creatinine ratio (ACR) test. It identifies more patients at-risk of chronic kidney disease (CKD) and associated cardiovascular disease (CVD), which is a leading cause of morbidity, disability and health inequalities. Damian O’Boyle, Director of Client Services at [...]
Sign up to our monthly health innovation newsletter